Coloplast AS (MEX:0QBON) Cyclically Adjusted FCF per Share: MXN77.61 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:0QBON Coloplast AS MEX:0QBON
80 GF Score
Price MXN1,875.47
GF Value MXN3,606.39
! 7 Warning Signs
View Full Analysis

What is Coloplast AS Cyclically Adjusted FCF per Share?

Coloplast AS MEX:0QBON 80 Cyclically Adjusted FCF per Share is MXN77.61 as of Mar. 2026. GuruFocus rates MEX:0QBON with a GF Score™ of 80/100 and a GF Value™ of MXN3,606.39. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Coloplast AS's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN12.596. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN77.61 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Coloplast AS's average Cyclically Adjusted FCF Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Coloplast AS was 9.70% per year. The lowest was 1.10% per year. And the median was 7.55% per year.

As of today (2026-08-10), Coloplast AS's current stock price is MXN1875.47. Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN77.61. Coloplast AS's Cyclically Adjusted Price-to-FCF of today is 24.17.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 20.97. And the median was 53.88.


Coloplast AS  (MEX:0QBON) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1875.47/77.61
=24.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 20.97. And the median was 53.88.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Coloplast AS Cyclically Adjusted FCF per Share Related Terms


Coloplast AS Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Cyclically Adjusted FCF per Share Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.00 50.25 46.63 38.39 59.68

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.81 53.03 59.68 60.89 77.61

MEX:0QBON vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted Price-to-FCF falls into.


MEX:0QBON
80GF Score
Coloplast AS MEX:0QBON
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=12.596/121.6800*121.6800
=12.596

Current CPI (Mar. 2026) = 121.6800.

Coloplast AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 5.899 100.600 7.135
201609 14.621 100.200 17.755
201612 1.957 100.300 2.374
201703 1.961 101.200 2.358
201706 12.205 101.200 14.675
201709 18.003 101.800 21.519
201712 11.910 101.300 14.306
201803 3.969 101.700 4.749
201806 17.066 102.300 20.299
201809 19.645 102.400 23.344
201812 9.025 102.100 10.756
201903 4.399 102.900 5.202
201906 16.550 102.900 19.570
201909 21.127 102.900 24.983
201912 10.615 102.900 12.552
202003 5.853 103.300 6.894
202006 19.855 103.200 23.410
202009 23.744 103.500 27.915
202012 -0.275 103.400 -0.324
202103 7.948 104.300 9.272
202106 17.481 105.000 20.258
202109 25.453 105.800 29.273
202112 13.594 106.600 15.517
202203 -0.263 109.900 -0.291
202206 17.665 113.600 18.921
202209 21.914 116.400 22.908
202212 2.771 115.900 2.909
202303 4.858 117.300 5.039
202306 10.298 116.400 10.765
202309 16.607 117.400 17.212
202312 16.726 116.700 17.440
202403 -30.514 118.400 -31.359
202406 13.376 118.500 13.735
202409 20.895 118.900 21.384
202412 22.112 118.900 22.629
202503 5.683 120.200 5.753
202506 15.666 120.700 15.793
202509 23.984 121.600 24.000
202512 22.822 121.200 22.912
202603 12.596 121.680 12.596

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN77.61 mean?
Coloplast AS (MEX:0QBON) has a Cyclically Adjusted FCF per Share of MXN77.61 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Coloplast AS and its competitors.
Is Coloplast AS's Cyclically Adjusted FCF per Share too high?
Coloplast AS's current Cyclically Adjusted FCF per Share is MXN77.61. Overall, Coloplast AS has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Coloplast AS's Cyclically Adjusted FCF per Share of MXN77.61 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Coloplast AS and its competitors. Coloplast AS's current Cyclically Adjusted FCF per Share is MXN77.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Coloplast AS (MEX:0QBON) has a current Cyclically Adjusted FCF per Share of MXN77.61. The stock's GF Value™ is MXN3,606.39, compared to a current price of MXN1,875.47 — trading 48% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN77.61. Coloplast AS's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Coloplast AS (MEX:0QBON), the current Cyclically Adjusted FCF per Share is MXN77.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (MEX:0QBON) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of MXN1,875.47 is trading 48% below its estimated GF Value™ of MXN3,606.39.

Key valuation signals for MEX:0QBON:

  • Cyclically Adjusted FCF per Share: MXN77.61
  • GF Value™: MXN3,606.39 vs. price of MXN1,875.47 (48% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the MEX:0QBON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
80GF Score

Get the complete analysis for MEX:0QBON

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,875.47
Price
MXN3,606.39
GF Value